Determining myeloperoxidase activity and protein concentration in a single assay: Utility in biomarker and

Muir Russell1, Nina Prokoph1, Neil Henderson1

  • 1Innovative Medicines and Early Development Biotech Unit, AstraZeneca, United Kingdom.

Insights

We developed a new assay to measure myeloperoxidase (MPO) activity and protein levels simultaneously. This combined assay simplifies MPO analysis in blood plasma for research into inflammatory and cardiovascular diseases.

Area of Science:

  • Biochemistry
  • Immunology
  • Clinical Chemistry

Background:

  • Myeloperoxidase (MPO) is a neutrophil enzyme crucial for microbial neutralization.
  • MPO's oxidative activity contributes to inflammation and diseases like cardiovascular and neurological disorders.
  • These disease links make MPO a significant biomarker and therapeutic target.

Purpose of the Study:

  • To develop and validate a single, combined assay for measuring both MPO activity and protein concentration.
  • To provide a streamlined method for MPO analysis in investigative laboratories.

Main Methods:

  • Construction and validation of a novel assay.
  • Utilized commercially available reagents.
  • Employed blood plasma samples for analysis.

Main Results:

  • Successfully created a single assay for simultaneous MPO activity and protein quantification.
  • The assay is validated for use with blood plasma samples.
  • The method allows for results generation within a single analytical run from one sample aliquot.

Conclusions:

  • A combined MPO activity and protein assay offers an efficient method for researchers.
  • This assay simplifies the analysis of MPO in plasma, supporting research in related diseases.
  • The validated assay can be readily adopted by investigative laboratories.

Related Concept Videos